Lactipro helps cows transition
A NEW natural product released in Australia is enabling farmers to change the way they feed concentrate to ruminants, suppling energy to the cow faster and more efficiently. Lactipro is the world’s first commercially available live culture of a patented strain of Megasphaera Elsdenii bacteria. It is APVMA registered and FDA approved. Dr Mark Connors, General Manager of BEC Biotech, highlighted the potential danger of transitioning from roughage to grain diets quickly. “This increases lactic acid production in the rumen which causes acidosis and can lead to a range of problems including poor milk production, reduced feed intake and even death” Dr Connors said. “Sub-clinical acidosis reduces cow performance but often goes unnoticed”. Controlling lactic acidosis in dairy cows whilst increasing energy supply can lead to an increase milk production and BCS, decrease subclinical ketosis and reduced culls due to metabolic disorders. “Lactipro’s benefits can be different for every farm. In addition to the production benefits other efficiencies including reduced roughage use, faster and more efficient transition to concentrate and the peace of mind from extra protection around acidosis” Dr Connors said. “Its biggest benefit is it allows the farmer to better and more efficiently manage their herd.” Distributed in Australia by BEC Biotech, Lactipro is produced in a built for purpose, customised fermentation laboratory in Brisbane and managed by a small, highly skilled team led by Dr Connors. “The most satisfying is when we have customers who have been using Lactipro tell us they have changed their management program because the product allows them to do this. It is rewarding to know you are making a difference.” Dr Connors said.